Evidence map›Paper›PMID 25744022›Full record

ArticleCell death and differentiation2015

The Fcp1-Wee1-Cdk1 axis affects spindle assembly checkpoint robustness and sensitivity to antimicrotubule cancer drugs.

R Visconti, R Della Monica, L Palazzo, F D'Alessio, M Raia, S Improta, M R Villa, L Del Vecchio, D Grieco

Open access · hybridAbstract read
In one paragraph

Article in Cell death and differentiation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Identification and Characterization of a NovelInternational journal of molecular sciences · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. WEE1 Inhibitor: Clinical Development.Current oncology reports · 2021
    Review
  10. Biology open · 2021
    Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

R Visconti1] CEINGE Biotecnologie Avanzate, Gaetano Salvatore 486, Naples 80145, Italy [2] IEOS, CNR, S. Pansini 5, Naples 80131, Italy.
R Della Monica1] CEINGE Biotecnologie Avanzate, Gaetano Salvatore 486, Naples 80145, Italy [2] DMMBM, University of Naples "Federico II", S. Pansini 5, Naples 80131, Italy.
L PalazzoSir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK.
F D'AlessioCEINGE Biotecnologie Avanzate, Gaetano Salvatore 486, Naples 80145, Italy.
M RaiaCEINGE Biotecnologie Avanzate, Gaetano Salvatore 486, Naples 80145, Italy.
S ImprotaDivision of Hematology, PO San Gennaro, ASL-NA1 Centro, Naples 80136, Italy.
M R VillaDivision of Hematology, PO San Gennaro, ASL-NA1 Centro, Naples 80136, Italy.
L Del Vecchio1] CEINGE Biotecnologie Avanzate, Gaetano Salvatore 486, Naples 80145, Italy [2] DMMBM, University of Naples "Federico II", S. Pansini 5, Naples 80131, Italy.
D Grieco1] CEINGE Biotecnologie Avanzate, Gaetano Salvatore 486, Naples 80145, Italy [2] DMMBM, University of Naples "Federico II", S. Pansini 5, Naples 80131, Italy.
Ceinge Biotecnologie Avanzate (Italy) · ITOspedale S.Gennaro · ITUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To grant faithful chromosome segregation, the spindle assembly checkpoint (SAC) delays mitosis exit until mitotic spindle assembly. An exceedingly prolonged mitosis, however, promotes cell death and by this means antimicrotubule cancer drugs (AMCDs), that impair spindle assembly, are believed to kill cancer cells. Despite malformed spindles, cancer cells can, however, slip through SAC, exit mitosis prematurely and resist killing. We show here that the Fcp1 phosphatase and Wee1, the cyclin B-dependent kinase (cdk) 1 inhibitory kinase, play a role for this slippage/resistance mechanism. During AMCD-induced prolonged mitosis, Fcp1-dependent Wee1 reactivation lowered cdk1 activity, weakening SAC-dependent mitotic arrest and leading to mitosis exit and survival. Conversely, genetic or chemical Wee1 inhibition strengthened the SAC, further extended mitosis, reduced antiapoptotic protein Mcl-1 to a minimum and potentiated killing in several, AMCD-treated cancer cell lines and primary human adult lymphoblastic leukemia cells. Thus, the Fcp1-Wee1-Cdk1 (FWC) axis affects SAC robustness and AMCDs sensitivity.

Indexed as

AdultAntineoplastic AgentsCDC2 Protein KinaseCell Cycle ProteinsCell Line, TumorCyclin-Dependent KinasesHeLa CellsHumansMicrotubulesM Phase Cell Cycle CheckpointsNeoplasmsNuclear ProteinsPhosphoprotein PhosphatasesPrecursor Cell Lymphoblastic Leukemia-LymphomaProtein-Tyrosine KinasesSpindle ApparatusAntineoplastic AgentsCDC2 Protein KinaseCDK1 protein, humanCell Cycle ProteinsCyclin-Dependent KinasesFcp1 protein, humanNuclear ProteinsPhosphoprotein PhosphatasesProtein-Tyrosine KinasesWEE1 protein, human

Identifiers

PMID25744022
PMCPMC4532778
OpenAlexW1967019500

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.